Checking a decision support tool for treating high cholesterol and blood fat disorders
Compares a computer decision tool's advice with past cholesterol treatment in 500 patients.
Plain-language title generated from the registry record
Registry title: Guideline Adherence in Dyslipidemia With Clinical Decision Support
Key facts
- Where
- Moscow, RussiaSee the site
Where in Russia
- 1 University HospitalMoscow, RussiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- I.M. Sechenov First Moscow State Medical University
- Trial code
- NCT07412457
- Record updated
- 24 February 2026
- Original description
Objective: To validate the performance of the developed clinical decision support system (CDSS) for participants with lipid metabolism disorders based on a decision tree algorithm.Read full original descriptionShow less
Assessment of Adherence to Clinical Practice Guidelines in Patients With Dyslipidemia Using a Clinical Decision Support System
Objective: To validate the performance of the developed clinical decision support system (CDSS) for participants with lipid metabolism disorders based on a decision tree algorithm.
Materials and Methods: A clinical decision support system for participants with lipid profile abnormalities will be developed using the Orbeon open-source online form creation platform based on current clinical guidelines.
During the CDSS pilot implementation, the electronic medical records (EMRs) of 500 participants from the Institute of Personalized Cardiology of the Biomedical Science and Technology Park at Sechenov University will be analyzed.
Retrospective data on prescribed lipid-lowering therapy extracted from the EHR will be compared with the CDSS recommendations. The accuracy of the decisions will be assessed by three independent experts based on digitized clinical and laboratory patient profiles.
The primary endpoint of the study will be to determine the accuracy of the system.
Results: This study will result in the development (creation) and pilot application of the CDSS program in participants with dyslipidemia in real clinical practice.
Conclusion: The developed CDSS system for dyslipidemia will significantly reduce the time required for clinical decision-making and help avoid errors in the interpretation of patient data.
Inclusion: Availability of the required amount of patient data for completion of the questionnaire-based system; Age 18 years or older; Signed informed consent to participate in the study; Non-inclusion criteria:; Patients with insufficient data to complete the questionnaire; Refusal to sign informed consent for participation in the study.
Exclusion: Absence of a consensus opinion on the clinical case among two of the three experts.